Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2012-06-13
2017-03-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupuncture for the Treatment of Posttraumatic Stress Among Military Personnel
NCT00320138
Acupuncture for PTSD
NCT02869646
3MDR to Treat PTSD With mTBI (3MDR)
NCT03796936
EEG Biofeedback in the Treatment of Chronic Treatment-Resistant PTSD
NCT01259921
The Use of Noninvasive Brain Stimulation in Post-traumatic Stress Disorder
NCT02542709
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acupressure Treatment
Active Acupressure Treatment
Participant will receive 8 active acupressure treatments.
Placebo Acupressure Treatment
Placebo Acupressure Treatment
Participants will receive 8 placebo acupressure treatments.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Acupressure Treatment
Participant will receive 8 active acupressure treatments.
Placebo Acupressure Treatment
Participants will receive 8 placebo acupressure treatments.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of mild TBI and PTSD as assessed by interview and/or chart review
* Currently receiving or eligible to receive physical and/or mental healthcare through the VA Eastern Colorado Health Care System
Exclusion Criteria
* History or diagnosis of lifetime moderate to severe TBI, as assessed by interview and/or chart review.
* History of psychotic disorder or bipolar I disorder as assessed by structured interview. Such conditions could affect outcome measures independently, thereby creating an experimental confound.
* Inability to read the informed consent document or adequately respond to questions regarding the informed consent procedure.
* Prior experience with acupressure, as this would result in individuals potentially being able to detect Placebo treatments if randomly assigned to that group.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Boulder
OTHER
United States Department of Defense
FED
VA Eastern Colorado Health Care System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lisa Brenner
Director of MIRECC (Mental Illness Research, Education and Clinical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Theresa D Hernandez, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Senior Investigator and Research Psychologist Eastern Colorado Healthcare System, VISN19, MIRECC
Lisa A Brenner, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Eastern Colorado Healthcare System VISN 19 MIRECC Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Denver VAMC
Denver, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COMIRB# 12-0452
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.